by Marilynn Marchione For the first time, a blood test has been shown to help detect many types of cancer in a study of thousands of people with no history or symptoms of the disease. The test is still experimental. Even its fans say it needs to be improved and that Tuesday’s results are not...
by Bob Marcotte, University of Rochester Medical Center “Is your pain tolerable?” A new study out today from the JAMA Network found that this simple question, used in conjunction with the traditional 0-10 rating scale posed to patients, could help doctors better understand whether treatments for pain, including opioid medications, are actually necessary. “Because of...
OCTOBER 17TH, 2019POSTED BY MATT SWAYNE-PENN STATE A machine learning system may be able to warn doctors and patients about possible negative side effects from drug-drug interactions. The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage or even death. For the study, researchers designed an algorithm...
The Food and Drug Administration on Wednesday approved a new drug to treat patients with multiple myeloma, overruling a panel of outside cancer experts who expressed concerns about its toxicity. The new multiple myeloma drug, called selinexor, will be marketed by Karyopharm Therapeutics under the brand name Xpovio. The FDA cleared Xpovio under an accelerated,...
by Krishna Ramanujan, Cornell University A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans. The treatment, developed by Cornell University biomedical engineers, is a synthetic version of a naturally occurring joint lubricant that binds to the surface of cartilage in joints and acts as a cushion during high-impact activities, such as running. “When...
by Amy Jeter Hansen, Stanford University Medical Center A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease. “For the first time in 18 years, we have a therapy for patients with Type 2 diabetes and chronic kidney disease that decreases kidney failure,” said Kenneth Mahaffey, MD, professor...
The U.S. Food and Drug Authority has adjusted the age range of women and men who can get the HPV vaccine Gardasil. The vaccine has previously been approved to be administered from the age of 9 up to 26, but doctors usually stop advising older adults to get their shots. The recent change will finally...
DripAssist by Shift Labs is an infusion rate monitor that offers a significant improvement in portability, efficiency, durability and ease of use over traditional infusion monitors. The last time Medgadget reported on Shift Labs, the company had just received their CE mark for DripAssist. The device is also FDA approved. Now, Shift Labs is announcing a partnership with Option Care Enterprises, one of...
Results from at-home genetic tests are not always accurate. A new study in the journal Genetics in Medicine, published by Springer Nature, now shows that up to 40 percent of direct-to-consumer (DTC) genetic tests provide incorrect readings in the raw data. Stephany Leigh Tandy-Connor, study leader at Ambry Genetics Corp in the US, expressed concern about...
